Pfizer Sweetens Its Offer for Metsera in Bidding War Against Novo

Pfizer Inc. has submitted a sweetened bid for obesity drug startup Metsera Inc. as its fight against rival Novo Nordisk A/S continues to escalate, according to people familiar with the...

By Michelle F Davis, Josh Sisco · Bloomberg Markets

Pfizer Inc. has submitted a sweetened bid for obesity drug startup Metsera Inc. as its fight against rival Novo Nordisk A/S continues to escalate, according to people familiar with the matter.